V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213349 | 20129258 | 1.72 | 73.4 | Adjuvant (A) | 2019-11-01 | 2019-11-28 | Panitumumab | 02 | N | PANITUMUMAB | 101740453 |
| 20213351 | 20129259 | 1.77 | 71.4 | Disease modification (D) | 2017-09-08 | 2017-09-09 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101117856 |
| 20213356 | 20129260 | 1.56 | 65.2 | Curative (C) | 2021-04-25 | 2021-05-07 | null | 02 | N | NIVOLUMAB | 100940057 |
| 20213359 | 20129262 | 1.75 | 73.3 | Palliative (P) | 2020-07-15 | 2020-07-22 | null | 2 | N | CISPLATIN + FLUOROURACIL | 100616159 |
| 20213363 | 20129263 | 1.79 | null | Palliative (P) | 2018-07-22 | 2018-08-22 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101627681 |
| 20213365 | 20129264 | 0 | 81.25 | null | 2019-05-28 | 2019-06-04 | null | 02 | null | PANITUMUMAB | 100959385 |
| 20213366 | 20129265 | 1.59 | 80.9 | Adjuvant (A) | 2013-01-13 | 2013-01-13 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100456776 |
| 20213367 | 20129266 | 1.78 | 66.9 | Palliative (P) | 2016-12-25 | 2017-01-06 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101317963 |
| 20213371 | 20129268 | null | null | Palliative (P) | 2018-04-02 | 2018-04-03 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100859083 |
| 20213373 | 20129269 | 1.72 | null | Palliative (P) | null | 2018-07-04 | null | 2 | N | NIVOLUMAB | 100234632 |
| 20213375 | 20129270 | 1.82 | 58.7 | Palliative (P) | 2018-11-28 | 2018-12-16 | null | null | N | NIVOLUMAB | 100790360 |
| 20213376 | 20129271 | 1.76 | 57.1 | Palliative (P) | 2020-05-10 | 2020-05-10 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100153452 |
| 20213377 | 20129272 | null | null | null | 2017-10-13 | 2017-11-24 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100973097 |
| 20213379 | 20129273 | 1.77 | null | null | null | 2019-09-16 | NIVOLUMAB | 2 | N | NIVOLUMAB | 100442120 |
| 20213381 | 20129275 | 1.75 | 72.4 | Curative (C) | null | 2018-02-24 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100749206 |
| 20213384 | 20129277 | 1.79 | 65.5 | Palliative (P) | 2016-08-08 | 2017-02-04 | ECX | 2 | Y | ECX | 101250466 |
| 20213387 | 20129278 | 1.73 | 81 | null | null | 2019-11-04 | Carboplatin + Etoposide iv&po | N | N | CARBOPLATIN + ETOPOSIDE | 101168547 |
| 20213388 | 20129279 | 1.59 | 62 | null | null | 2016-03-28 | ECX | 02 | null | ECX | 100650981 |
| 20213390 | 20129280 | 1.59 | 69.8 | Palliative (P) | 2017-06-06 | 2017-06-15 | null | N | N | ECX | 100070068 |
| 20213393 | 20129281 | 1.59 | 60 | Palliative (P) | 2017-12-12 | 2017-12-26 | ECX | 02 | N | ECX | 101611575 |
| 20213395 | 20129282 | 1.64 | 76 | null | 2017-04-09 | 2017-04-28 | null | 2 | N | CISPLATIN + FLUOROURACIL | 100592217 |
| 20213396 | 20129283 | 1.72 | 79.6 | Adjuvant (A) | 2019-04-29 | 2019-05-06 | ECX | 2 | N | ECX | 101269853 |
| 20213402 | 20129287 | 1.8 | 84.7 | Palliative (P) | 2019-06-17 | 2019-06-20 | null | null | Y | PANITUMUMAB | 101523000 |
| 20213408 | 20129288 | 1.52 | 80 | null | null | 2016-03-31 | Panitumumab | 02 | N | PANITUMUMAB | 100778770 |
| 20213409 | 20129289 | null | null | null | 2017-12-18 | 2018-12-10 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101533681 |
| 20213411 | 20129290 | null | 55.6 | Palliative (P) | 2017-01-12 | 2017-02-03 | Cisplatin + Fluorouracil + RT 5day | N | N | CISPLATIN + FLUOROURACIL | 100307502 |
| 20213412 | 20129291 | 1.85 | 151.2 | Palliative (P) | 2018-01-20 | 2018-02-03 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101482213 |
| 20213415 | 20129294 | 1.73 | 72.8 | Palliative (P) | 2019-05-21 | 2019-05-23 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100182408 |
| 20213418 | 20129295 | 1.62 | 50 | Palliative (P) | 2018-09-17 | 2019-08-28 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100486281 |
| 20213422 | 20129296 | 1.56 | 71.6 | null | 2018-03-26 | 2019-07-20 | NIVOLUMAB | null | null | NIVOLUMAB | 100920495 |
| 20213424 | 20129297 | 1.64 | null | null | 2017-10-12 | 2017-10-23 | ECX | 02 | N | ECX | 101466472 |
| 20213426 | 20129298 | 1.69 | 66.7 | null | 2019-01-01 | 2019-01-24 | null | null | null | ECX | 100267610 |
| 20213430 | 20129300 | 1.64 | 65.15 | Palliative (P) | 2016-10-30 | 2016-10-30 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101724154 |
| 20213434 | 20129301 | 1.6 | 67.85 | Palliative (P) | 2020-04-08 | 2020-04-08 | null | 02 | N | NIVOLUMAB | 100998505 |
| 20213438 | 20129302 | 1.58 | 96.2 | Neo-adjuvant (N) | 2020-02-19 | 2020-03-14 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100005462 |
| 20213439 | 20129303 | 1.6 | null | Adjuvant (A) | 2017-08-01 | 2017-09-03 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100772635 |
| 20213442 | 20129304 | 1.63 | 68 | Palliative (P) | 2019-03-31 | 2019-03-31 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100296120 |
| 20213444 | 20129305 | 1.78 | 65.6 | null | 2020-12-10 | 2020-12-10 | null | 02 | N | ECX | 101651953 |
| 20213446 | 20129306 | 1.73 | null | Palliative (P) | 2020-01-12 | 2020-01-12 | Panitumumab | 02 | null | PANITUMUMAB | 101093521 |
| 20213454 | 20129309 | 1.64 | 85 | Palliative (P) | 2019-01-23 | 2019-02-08 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100597527 |
| 20213456 | 20129310 | 1.69 | 85 | Palliative (P) | 2018-03-15 | 2018-03-26 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100374260 |
| 20213457 | 20129311 | 1.69 | 84.4 | Palliative (P) | 2018-07-28 | 2018-09-08 | EOX | 2 | null | TRIAL | 100180843 |
| 20213460 | 20129312 | 1.79 | 90.6 | null | 2019-10-31 | 2020-01-06 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101821807 |
| 20213461 | 20129313 | 1.79 | 61 | Palliative (P) | 2017-05-29 | 2017-07-31 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100868889 |
| 20213462 | 20129314 | 1.71 | 62.9 | Neo-adjuvant (N) | 2017-01-12 | 2018-07-09 | CETUXIMAB + OXALIPLATIN + MDG | 99 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100467387 |
| 20213463 | 20129315 | 1.79 | 78.8 | Palliative (P) | null | 2018-12-03 | Trial Unspecified | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101186541 |
| 20213464 | 20129316 | 1.76 | 54.4 | Disease modification (D) | 2018-04-08 | 2018-04-29 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101815671 |
| 20213470 | 20129317 | 1.6 | 95 | Curative (C) | 2022-01-11 | 2022-01-29 | IRINOTECAN + MDG + PANITUMUMAB | Y | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100121648 |
| 20213471 | 20129318 | 1.72 | 64 | Palliative (P) | 2016-05-25 | 2017-06-14 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100278900 |
| 20213474 | 20129319 | 1.7 | 84.3 | Curative (C) | 2017-09-03 | 2017-09-08 | EOX | 1 | Y | CETUXIMAB + IRINOTECAN + MDG | 100089339 |